• Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Home
  • About Us
  • Blog
  • Subscribe to the Journal
  • Contact Us
Sleep Diagnosis and Therapy

Sleep Diagnosis and Therapy

Official Publication of the American Sleep and Breathing Academy

In-Person Pharma Visits Take a Popularity Hit

July 25, 2014 by admin

 

Physicians have always been protective of their time, and that trend is only continuing in the digital age. So-called “mobile savvy” docs, in particular, are less inclined to welcome pharma rep visits, but they are still open to receiving industry information.

 

The information comes courtesy of ZS Associates, as published on www.pmlive.com. Pratap Khedkar, principal and leader of the pharmaceuticals practice at ZS Associates, said: “It’s not that these doctors object to receiving information from pharmaceutical companies. These doctors merely prefer using mobile and other alternative channels of communication to engage with reps.

 

“To take advantage of this change, companies must adopt an integrated ‘surround sound’ approach that uses several alternative methods to capture and keep a doctor’s attention,” he continued. “The trend is moving toward a mix of face-to-face communication with a handful of digital communication channels orchestrated by the rep.”

 

“The consultants’ AccessMonitor report found the decrease in physician access was also being driven by greater demands on doctors’ time and growth in payer/provider consolidation,” writes blogger Dominic Tyer. “Previously rep-friendly specialists, such as those in dermatology, gastroenterology and paediatrics, were also found to be rapidly losing interest in rep visits.”

 

The AccessMonitor report aggregates sales-call summaries from more than 200 US pharma sales teams and examines how often approximately 325,000 physicians and other prescribers meet with the sales reps that try to visit them.

 

“Physician access has been steadily declining over the last six years and nearly half (49%) of those in the US now have ‘moderate-to-severe’ restrictions on rep visits in place – up from 23 per cent in 2008,” writes Tyer. “Access continues to worsen despite cuts in the size of pharma’s field forces – last year Lilly set out plans to axe a third of its US reps and Novartis has already made major reductions, for example. As a result of these and other decisions the industry employs more reps in China than it does in the US.”

 

Khedkar adds: “While it’s discouraging that doctors may not meet as often with pharma reps, most physicians still view these reps as valuable sources of information. Pharma companies just need to find new ways to reach these customers.”

Filed Under: Articles, Blog

Primary Sidebar

More to See

Snoring, American Sleep and Breathing Academy and the NY Times

August 23, 2022 By admin

Jazz Pharma Presents 17 New Posters for SLEEP 2022

June 6, 2022 By admin

Tags

apnea CPAP Health Home Sleep Home Sleep Testing insomnia narcolepsy obstructive sleep apnea Sleep sleep apnea sleep apnea symptoms sleep apnea syndrome sleep apnea treatment sleep appliances sleep buisness Sleep Business sleep center Sleep Centers sleep community sleep diagnosis sleep diagnostic sleep diagnostics sleep disease sleep disorder sleep disorder center sleep disordered breathing sleep disorders sleep heart health sleep industry sleeping Sleep Lab sleep labs sleep management sleep medicine sleep monitor sleep physicians sleep problems sleep studies sleep study sleep technologist sleep test sleep testing Technology therapy Treatment

Footer

About SleepDT

SleepDT Sleep Diagnosis and Therapy is a clinical Journal for allied Sleep Professionals, Neurologists, Psychiatrists, Pulmonologists, Primary Care Physicians, and other medical specialists. We also advocate on behalf of patient care in the field of Sleep Medicine

Recent

  • SUPPORT AND PROMOTE DENTAL SLEEP MEDICINE IN 2023!
  • Snoring, American Sleep and Breathing Academy and the NY Times
  • Jazz Pharma Presents 17 New Posters for SLEEP 2022
  • AJMC Hypes SLEEP 2022
  • Avadel Pharmaceuticals’ Stock Falls

NAVIGATION

  • Home
  • About Us
  • Blog
  • Subscribe to the Journal
  • Contact Us

Copyright © 2023 · Sleep Diagnosis and Therapy